Search

Your search keyword '"Wang, Xuan-Yi"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Wang, Xuan-Yi" Remove constraint Author: "Wang, Xuan-Yi"
241 results on '"Wang, Xuan-Yi"'

Search Results

5. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024

6. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

9. Report from the World Health Organization’s immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024

11. Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9–45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial

12. Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study

14. Effectiveness of vero cell inactivated vaccine against severe acute respiratory infections (SARI) in Sibu, Malaysia: A retrospective test-negative design

15. Molecular epidemiology analysis of symptomatic and asymptomatic norovirus infections in Chinese infants

16. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study

18. Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study.

20. A case–case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants

21. Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial

25. Additional file 1 of Genetic characterization of two G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21: evidence of genome reassortment

27. Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial

30. Long‐term persistence of anti‐HAV antibody conferred by a single dose of live‐attenuated hepatitis A vaccine: Results from 17‐year follow‐up

32. Additional file 1 of Burden and etiology of moderate and severe diarrhea in children less than 5 years of age living in north and south of China: Prospective, population-based surveillance

33. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004/Tendances et fardeau du cholera dans la province du Guangxi en Chine, 1994-2004 /Tendencias v carga de la fiebre tifoidea en la provincia de Guangxi, China, entre 1994 y 2004

37. Trend and disease burden of bacillary dysentery in China (1991-2000)/Evolution de la dysenterie bacillaire et charge de morbidite due a cette maladie en Chine (1991-2000)/Disenteria bacilar: tendencias y carga de morbilidad en China (1991-2000)

39. Burden and Etiology of Moderate and Severe Diarrhea in Chinese Children Less than 5 years of Age: Prospective, Population-based Surveillance

40. Genetic susceptibility to rotavirus infection in Chinese children: a population-based case–control study

41. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique

46. Long-Term Persistence of Anti-HAV Antibody Conferred by a Single Dose of Live-Attenuated Hepatitis A Vaccine: Results from 17-Year Follow-Up

47. In-depth mining of clinical data: the construction of clinical prediction model with R

Catalog

Books, media, physical & digital resources